Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Alice Franzoi

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
AIDS (London, England)|January 4, 2021
Impact of HIV infection on baseline characteristics and survival of women with breast cancerMariana Brandão, Marco Bruzzone, Maria-Alice Franzoi, et al.
Journal of the National Cancer Institute|August 5, 2020
Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine TherapyMaria Alice Franzoi, Daniel Eiger, Lieveke Ameye, et al.
Breast Cancer Research : BCR|October 28, 2020
Effect of body mass index on response to neo-adjuvant therapy in HER2-positive breast cancer: an exploratory analysis of the NeoALTTO trialSerena Di Cosimo, Luca Porcu, Dominique Agbor-Tarh, et al.
Breast (Edinburgh, Scotland)|April 9, 2026
Understanding the patient journey: Barriers, facilitators, and expectations in joining a chemotherapy de-escalation trial among premenopausal patients with breast cancerPetya Zyumbileva, Tanja Spanic, Emma Gillanders, et al.
European Journal of Cancer (Oxford, England : 1990)|June 17, 2026
Body mass index in postmenopausal women with estrogen receptor-positive, HER2-negative early breast cancer: An exploratory analysis of the LORELEI trialChiara Dauccia, Maria Alice Franzoi, Cristina Saura, et al.
Breast (Edinburgh, Scotland)|February 6, 2026
Association between body mass index and risk of breast cancer according to breast cancer subtypes: A systematic review and meta-analysisChiara Dauccia, Marco Bruzzone, Luca Arecco, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 16, 2026
Aromatase Inhibitor-Induced Arthralgia Among Patients With Early Breast Cancer: Prevalence, Treatment Nonadherence, and Management in a Prospective Longitudinal CohortPietro Lapidari, Maryam B Lustberg, Julie Havas, et al.
Breast Cancer Research and Treatment|February 10, 2026
ATTITUDE - Addressing attrition in longitudinal cancer cohorts: an in-depth qualitative analysis of experiences and perspectives on participation in longitudinal studies among breast cancer survivorsElise Martin, Mariam Chichua, Camila Kelly Chiodi, et al.
The Lancet Regional Health. Europe|October 24, 2024
Implementation of a remote symptom monitoring pathway in oncology care: analysis of real-world experience across 33 cancer centres in France and BelgiumMaria Alice Franzoi, Arlindo R Ferreira, Antoine Lemaire, et al.
JAMA Network Open|November 16, 2023
Chemotherapy-Related Amenorrhea and Quality of Life Among Premenopausal Women With Breast CancerRayan Kabirian, Maria Alice Franzoi, Julie Havas, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
AIDS (London, England)|January 4, 2021
Impact of HIV infection on baseline characteristics and survival of women with breast cancerMariana Brandão, Marco Bruzzone, Maria-Alice Franzoi, et al.
Journal of the National Cancer Institute|August 5, 2020
Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine TherapyMaria Alice Franzoi, Daniel Eiger, Lieveke Ameye, et al.
Breast Cancer Research : BCR|October 28, 2020
Effect of body mass index on response to neo-adjuvant therapy in HER2-positive breast cancer: an exploratory analysis of the NeoALTTO trialSerena Di Cosimo, Luca Porcu, Dominique Agbor-Tarh, et al.
Breast (Edinburgh, Scotland)|April 9, 2026
Understanding the patient journey: Barriers, facilitators, and expectations in joining a chemotherapy de-escalation trial among premenopausal patients with breast cancerPetya Zyumbileva, Tanja Spanic, Emma Gillanders, et al.
European Journal of Cancer (Oxford, England : 1990)|June 17, 2026
Body mass index in postmenopausal women with estrogen receptor-positive, HER2-negative early breast cancer: An exploratory analysis of the LORELEI trialChiara Dauccia, Maria Alice Franzoi, Cristina Saura, et al.
Breast (Edinburgh, Scotland)|February 6, 2026
Association between body mass index and risk of breast cancer according to breast cancer subtypes: A systematic review and meta-analysisChiara Dauccia, Marco Bruzzone, Luca Arecco, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 16, 2026
Aromatase Inhibitor-Induced Arthralgia Among Patients With Early Breast Cancer: Prevalence, Treatment Nonadherence, and Management in a Prospective Longitudinal CohortPietro Lapidari, Maryam B Lustberg, Julie Havas, et al.
Breast Cancer Research and Treatment|February 10, 2026
ATTITUDE - Addressing attrition in longitudinal cancer cohorts: an in-depth qualitative analysis of experiences and perspectives on participation in longitudinal studies among breast cancer survivorsElise Martin, Mariam Chichua, Camila Kelly Chiodi, et al.
The Lancet Regional Health. Europe|October 24, 2024
Implementation of a remote symptom monitoring pathway in oncology care: analysis of real-world experience across 33 cancer centres in France and BelgiumMaria Alice Franzoi, Arlindo R Ferreira, Antoine Lemaire, et al.
JAMA Network Open|November 16, 2023
Chemotherapy-Related Amenorrhea and Quality of Life Among Premenopausal Women With Breast CancerRayan Kabirian, Maria Alice Franzoi, Julie Havas, et al.
Pageof 5